» Authors » Juan Pardo-Montero

Juan Pardo-Montero

Explore the profile of Juan Pardo-Montero including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 42
Citations 144
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fenwick J, Kumar S, Pardo-Montero J
Phys Med Biol . 2024 Jul; 69(15). PMID: 39013400
To derive a collection efficiency formula,fGauss, for cylindrical ionization chambers in pulsed radiation beams from a volume recombination model of Boag(1996885-97) including free electrons. To validatefGaussand a parallel plate chamber...
2.
Pardo-Montero J, Pombar M, Gomez-Caamano A, Giordanengo S, Gonzalez-Crespo I
Med Phys . 2023 Oct; 50(11):7304-7312. PMID: 37818904
Background: In treatment planning for proton therapy a constant Relative Biological Effectiveness (RBE) of 1.1 is used, disregarding variations with linear energy transfer, clinical endpoint, or fractionation. Purpose: To present...
3.
Pardo-Montero J, Gonzalez-Crespo I, Gomez-Caamano A, Gago-Arias A
Cancers (Basel) . 2023 Jul; 15(14). PMID: 37509320
The purpose of this work was to investigate the response of prostate cancer to different radiotherapy schedules, including hypofractionation, to evaluate potential departures from the linear-quadratic (LQ) response, to obtain...
4.
Paz-Martin J, Schuller A, Bourgouin A, Gonzalez-Castano D, Gomez-Fernandez N, Pardo-Montero J, et al.
Phys Med . 2022 Nov; 103:147-156. PMID: 36327676
Purpose: Air-vented ionization chambers have been the secondary standard for radiation dosimetry since the origins of radiation metrology. However, the feasibility of their use in ultra-high dose rate pulsed beams...
5.
Gonzalez-Crespo I, Gomez-Caamano A, Pouso O, Fenwick J, Pardo-Montero J
IEEE/ACM Trans Comput Biol Bioinform . 2022 May; 20(2):808-821. PMID: 35544486
There is evidence of synergy between radiotherapy and immunotherapy. Radiotherapy can increase liberation of tumor antigens, causing activation of antitumor T-cells. This effect can be boosted with immunotherapy. Radioimmunotherapy has...
6.
Gomez F, Gonzalez-Castano D, Fernandez N, Pardo-Montero J, Schuller A, Gasparini A, et al.
Med Phys . 2022 Apr; 49(7):4705-4714. PMID: 35416306
Background: Conventional air ionization chambers (ICs) exhibit ion recombination correction factors that deviate substantially from unity when irradiated with dose per pulse magnitudes higher than those used in conventional radiotherapy....
7.
Neira S, Gago-Arias A, Gonzalez-Crespo I, Guiu-Souto J, Pardo-Montero J
Pharmaceutics . 2021 Sep; 13(9). PMID: 34575575
Pharmacokinetic modeling of the radiopharmaceuticals used in molecular radiotherapy is an important step towards accurate radiation dosimetry of such therapies. In this paper, we present a pharmacokinetic model for CLR1404,...
8.
Neira S, Guiu-Souto J, Pais P, Rodriguez Martinez de Llano S, Fernandez C, Pubul V, et al.
Med Phys . 2021 Jul; 48(9):5448-5458. PMID: 34260065
Purpose: To obtain individualized internal doses with a Monte Carlo (MC) method in patients undergoing diagnostic [18F]FCH-PET studies and to compare such doses with the MIRD method calculations. Methods: A...
9.
Gago-Arias A, Neira S, Pombar M, Gomez-Caamano A, Pardo-Montero J
Radiother Oncol . 2021 May; 161:1-8. PMID: 34015386
Background And Purpose: To investigate the possible contribution of indirect damage and damage saturation to tumour control obtained with SBRT/SRS treatments for early-stage NSCLC and brain metastases. Methods And Materials:...
10.
Pardo-Montero J, Parga-Pazos M, Fenwick J
Med Phys . 2021 Mar; 48(7):4075-4084. PMID: 33704792
Purpose: The purpose of this study is to present a biomathematical model based on the dynamics of cell populations to predict the tolerability/intolerability of mucosal toxicity in head-and-neck radiotherapy. Methods...